GEN:NYE-Genesis Healthcare Inc. (USD)

EQUITY | Software - Infrastructure | New York Stock Exchange

Last Closing

USD 27.65

Change

0.00 (0.00)%

Market Cap

USD 0.52B

Volume

1.97M

Analyst Target

USD 1.38
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Genesis Healthcare Inc is a post-acute care provider. The Company operates skilled nursing centers and assisted/senior living communities. The Company also supplies rehabilitation and respiratory therapy.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-29 )

Largest Industry Peers for Software - Infrastructure

Symbol Name Price(Change) Market Cap
MSFT Microsoft Corporation

N/A

USD 3,200.94B
ADBE Adobe Systems Incorporated

N/A

USD 242.08B
PANW Palo Alto Networks Inc

N/A

USD 122.57B
CRWD Crowdstrike Holdings Inc

N/A

USD 89.24B
SNPS Synopsys Inc

N/A

USD 78.38B
FTNT Fortinet Inc

N/A

USD 75.07B
ZS Zscaler Inc

N/A

USD 28.75B
KSPI Joint Stock Company Kaspi.kz A..

N/A

USD 20.91B
CHKP Check Point Software Technolog..

N/A

USD 20.65B
MDB MongoDB

N/A

USD 19.90B

ETFs Containing GEN

BUG:XETRA Global X Cybersecurity UC.. 5.76 % 0.00 %

N/A

USD 0.02B
BUGG:AU Global X Cybersecurity ET.. 5.74 % 0.00 %

N/A

N/A
USPY:F Legal & General UCITS ETF.. 5.73 % 0.00 %

N/A

N/A
BUGU:SW Global X Cybersecurity UC.. 5.55 % 0.00 %

N/A

N/A
RCRS:F Rize UCITS ICAV - Rize Cy.. 5.48 % 0.00 %

N/A

USD 0.13B
BUG:LSE Global X Cybersecurity UC.. 5.29 % 0.00 %

N/A

USD 0.04B
ISPY:SW L&G Cyber Security UCITS .. 5.15 % 0.00 %

N/A

USD 2.53B
CYBR:SW Rize UCITS ICAV - Rize Cy.. 4.85 % 0.00 %

N/A

N/A
CBRS:XETRA First Trust Nasdaq Cybers.. 4.33 % 0.00 %

N/A

USD 0.43B
HACK:AU Betashares Global Cyberse.. 4.10 % 0.00 %

N/A

USD 0.94B
CBUG:CA CI Digital Security Index.. 4.05 % 0.00 %

N/A

CAD 2.89M
FPXE:LSE First Trust IPOX® Europe.. 4.02 % 0.00 %

N/A

USD 1.36M
FPXE First Trust IPOX Europe E.. 3.85 % 0.00 %

N/A

USD 3.86M
FPXI First Trust International.. 3.73 % 0.70 %

N/A

USD 0.13B
KNGU:CA Brompton U.S. Cash Flow K.. 3.46 % 0.00 %

N/A

CAD 6.54M
ZLU:CA BMO Low Volatility US Equ.. 1.64 % 0.33 %

N/A

CAD 1.91B
IQSM Iq Candriam ESG U.S. Mid .. 0.86 % 0.00 %

N/A

N/A
ZLU-U:CA BMO Low Volatility US Equ.. 0.00 % 0.00 %

N/A

N/A
USPY:LSE L&G Cyber Security UCITS .. 0.00 % 0.00 %

N/A

USD 2.55B
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

N/A

USD 0.22B
USPY:XETRA L&G Cyber Security UCITS .. 0.00 % 0.00 %

N/A

USD 2.62B
RCRS:XETRA Rize UCITS ICAV - Rize Cy.. 0.00 % 0.00 %

N/A

USD 0.13B
BUG Global X Cybersecurity ET.. 0.00 % 0.00 %

N/A

USD 0.82B
CIBR:LSE First Trust Nasdaq Cybers.. 0.00 % 0.00 %

N/A

USD 0.85B
QDIV Global X S&P 500® Qualit.. 0.00 % 0.00 %

N/A

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Software - Infrastructure) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.17% 63% D 75% C
Dividend Return 2.19% 100% F 39% F
Total Return 23.36% 63% D 75% C
Trailing 12 Months  
Capital Gain 21.17% 63% D 75% C
Dividend Return 2.19% 100% F 39% F
Total Return 23.36% 63% D 75% C
Trailing 5 Years  
Capital Gain 1,585.98% 98% N/A 99% N/A
Dividend Return 884.15% 100% F 100% F
Total Return 2,470.12% 98% N/A 99% N/A
Average Annual (5 Year Horizon)  
Capital Gain 2,151.90% 98% N/A 98% N/A
Dividend Return 2,152.51% 98% N/A 98% N/A
Total Return 0.62% 33% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 3,796.41% 3% F 3% F
Risk Adjusted Return 56.70% 88% B+ 81% B-
Market Capitalization 0.52B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Software - Infrastructure) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector